Cancer Imaging and Therapy with Bispecific Antibody Pretargeting. - Wikidata - wikimedia - TriplyDB

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

http://www.wikidata.org/entity/Q36082355

about

Bispecific digoxigenin-binding antibodies for targeted payload delivery Structure-based design of a streptavidin mutant specific for an artificial biotin analogue Pretargeted Positron Emission Tomography Imaging That Employs Supramolecular Nanoparticles with in Vivo Bioorthogonal Chemistry High-Throughput Approaches to the Development of Molecular Imaging Agents.Molecular Imaging of Pancreatic Cancer with Antibodies.Modern Technologies for Creating Synthetic Antibodies for Clinical application.Clinical Pharmacology and Translational Aspects of Bispecific Antibodies Engineering an antibody with picomolar affinity to DOTA chelates of multiple radionuclides for pretargeted radioimmunotherapy and imaging.Pretargeted radioimmunotherapy for hematologic and other malignancies Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies?High efficiency diffusion molecular retention tumor targeting.Immunolymphoscintigraphy for metastatic sentinel nodes: test of a model Recent trends in antibody-based oncologic imaging Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.Molecular imaging of bacterial infections in vivo: the discrimination of infection from inflammation.PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer.A self-assembling short oligonucleotide duplex suitable for pretargeting Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.Engineered proteins pull double duty.Pretargeted molecular imaging and radioimmunotherapy.RECRUIT-TandAbs: harnessing the immune system to kill cancer cells.Development and prospects for bispecific antibody-based therapeutics in cancer and other applications.Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.A leucine zipper pair-based lipid vesicle for image-guided therapy in breast cancer.Development of an enzymatic pretargeting strategy for dual-modality imaging.Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.Novel Carcinoembryonic-Antigen-(CEA)-Specific Pretargeting System to Assess Tumor Cell Viability after Irradiation of Colorectal Cancer Cells.Use of SpyTag/SpyCatcher to construct bispecific antibodies that target two epitopes of a single antigen.Adamantane/Cucurbituril: A Potential Pretargeted Imaging Strategy in Immuno-PET Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies

P2860

Q27667652-A30654DA-969E-40BB-8E61-7DCAF560F228 Q27697883-2A25DF17-FDDE-47F9-A31F-7BF5775B0855 Q28829134-9550481E-8FC1-4558-8C5B-22775C0D0F1E Q30275493-971AF694-A9EC-40CA-AD62-8D3D55A48B8B Q30393523-DFCAFB88-1672-45DA-9D49-08757C9179CB Q30467308-92E82FED-85C0-480A-A6EF-0E4D3B8FB5BC Q33648086-3631AB87-B8B8-4BA6-A577-C777B518381A Q33661948-9F0D947E-7162-4759-A07D-F54D84E1CF02 Q34113941-0975C0A5-AB78-438F-B357-4A671FDD5B5C Q34335207-5EF576EA-DBE0-4717-9A5A-04FA73CE733A Q34625694-28401A54-0E6F-4D9F-B667-35D7641E9796 Q34982566-D3C02459-913B-46F1-B439-552B47C73D6E Q35643425-0697058B-685E-4DCB-BED1-60B4F98EAA85 Q36395999-2FB5F8F4-EA4E-4273-8ADA-D0EE6E0F2E04 Q36683890-8C8A59FE-22B2-4009-AB03-9B50C619CD5F Q36911658-B90742A9-78EB-458C-9095-10DEE6D2418A Q37044940-E8D1458C-6A9B-49D3-88A6-1BCA2446C070 Q37515337-F040F8A8-CAFB-4E92-8329-6422A3EDF9B3 Q37725479-62FE3D87-C947-40DF-B726-626C26607D53 Q38022016-87AFF417-18B8-44AA-BFA4-C4051F5511BB Q38024123-E1A2AE49-AF5F-497F-990B-48AEB0AF7600 Q38090680-5B56DB1D-4351-4A94-A68D-7218EF03CEDF Q38206206-EFE885BC-9BE6-4C2B-8432-052C82A4BC1F Q38804836-E54D0CEB-85A1-4E88-B0E0-ACFBAF2E31A2 Q38912048-8E36E8F0-FB74-41CB-A171-B65005CFA94F Q39402193-6008D6CF-F8D4-4117-BE1C-C6E12BA8502C Q39486574-A8561980-5C83-4BBD-835E-5E3CA0B16D25 Q39602064-0620AD97-365B-428F-917E-26693D924723 Q47997819-5CFE8E2C-E2AE-4FBE-8839-40DBE230E173 Q57826559-8579A591-C5FE-4481-AA67-0C4FA9F58CAC Q58724935-F0A5A3BE-7A4B-4831-AC85-CAA00F42F88E

P2860

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

http://www.wikidata.org/entity/Q36082355

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

@ast

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

@en

type

label

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

@ast

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

@en

prefLabel

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

@ast

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

@en

P1433

Q36082355-35CE5D89-64F6-4218-A429-5DDE03423C47

P1476

Q36082355-9FB77304-E292-4A94-A95E-6019C8482061

P2093

Q36082355-1E80F8A5-4E9F-49E9-9924-519421064218

Q36082355-2955879E-D38E-438C-8130-792EDDC139E9

Q36082355-6D450357-F6FF-466B-91CD-7029A5C7664F

Q36082355-C0CA0D5E-C862-4661-BFF3-2354E007148C

P2860

Q36082355-004CB5EB-26C2-48C6-9675-3FCB3148ECB3

Q36082355-0524B771-0C19-4B71-909B-D41EF37B47B8

Q36082355-0AAA584F-BC86-479B-9FEA-9178BB60F468

Q36082355-0E155E98-D7F2-44E8-9754-7B89417FBF8A

Q36082355-0E57E921-C28E-4E8A-A007-7276ACDEAE42

Q36082355-1904A934-6A0B-48F8-98BF-AC9C782F7422

Q36082355-1E6971E3-72D1-4D9B-817D-75627CE53E59

Q36082355-20120CF5-66F1-42EA-BE83-6E3AA6B40FC1

Q36082355-265A1691-81F5-4F27-AB73-7A3588802F70

Q36082355-30358107-7176-445F-BDE9-D8581C78EAB3

P304

Q36082355-EC4B1181-0062-429C-9B4F-17A5C88D9A47

P31

Q36082355-A24F6C65-A3B7-4E3D-A342-ED69C636CA08

P356

Q36082355-AFCE0A07-CD6C-4E05-8D5F-6DC848F97BAA

P433

Q36082355-9A668F33-F366-4139-B165-C5BD55EE72A4

P478

Q36082355-8CB28614-CCA1-440E-9CD7-709778AA4955

P50

Q36082355-4F9565DB-4283-4237-B8D1-EDE2A388A22D

P577

Q36082355-34CE57B3-391B-45DA-B4A6-EB8986FF55C4

P5875

Q36082355-FB8F2AD7-1F8B-4909-9632-BC1D25FFCC93

P698

Q36082355-A4749D7C-BC80-4B32-8CC5-C6FDD25B4AF2

P921

Q36082355-13848D9E-D000-4056-A492-574C6A131A35

P932

Q36082355-52FE18FC-54D6-4BD3-BA05-4F9EAD103C95

P356

J.UCT.2007.04.003

P1433

Update on Cancer Therapeutics

P1476

Cancer Imaging and Therapy with Bispecific Antibody Pretargeting.

@en

P2093

David M Goldenberg

http://www.w3.org/2001/XMLSchema#string

Jacques Barbet

http://www.w3.org/2001/XMLSchema#string

Jean-Francois Chatal

http://www.w3.org/2001/XMLSchema#string

Robert M Sharkey

http://www.w3.org/2001/XMLSchema#string

P2860

Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development

Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.

Engineering novel binding proteins from nonimmunoglobulin domains.

A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma.

Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.

Recombinant antibody constructs in cancer therapy.

The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy.

Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.

Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting.

P304

19-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UCT.2007.04.003

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Otto C. Boerman

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5541703

http://www.w3.org/2001/XMLSchema#string

P698

18311322

http://www.w3.org/2001/XMLSchema#string

P921

P932

2034280

http://www.w3.org/2001/XMLSchema#string